HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently.

AbstractBACKGROUND:
ST-246 is a potent anti-orthopoxviral molecule targeting the F13L protein of vaccinia virus, which is involved in the wrapping of viruses. The discrepancy in sensitivities of several orthopoxviruses to ST-246 has raised questions about potential differences in their replicative cycles and/or the presence of another drug target.
METHODS:
Density gradients were used to evaluate the differences between the viral cycles of vaccinia, cowpox and camelpox viruses. Also, to investigate if ST-246 inhibits a single target, we compared its activity to that of small interfering RNAs designed to silence the F13L gene (siF13Ls).
RESULTS:
We showed that the spread of vaccinia virus involved both intracellular and extracellular enveloped viruses, whereas both cowpox and camelpox viruses seemed to propagate via non-enveloped intracellular forms and cell-associated viral particles. Although ST-246 exerted a clear antiviral activity by interfering with the egress of the virus from infected cells, we observed that cowpox and camelpox viruses, in contrast to vaccinia virus, could be directed towards a lytic cycle under ST-246 treatment. We specifically knocked down the F13L transcripts of vaccinia and camelpox viruses by > 85%, reduced virus progeny by 90% and showed that siF13Ls affect camelpox and vaccinia virus propagation differently. Flow cytometry data validated that ST-246 interfered with the activity of the F13L protein, whereas siF13Ls silenced the F13L gene.
CONCLUSIONS:
Our observations support that vaccinia, cowpox and camelpox viruses exhibit different levels of sensitivity to ST-246 because of dissimilarities between their ways of propagation, and provide a better understanding of the mode of action of ST-246.
AuthorsSophie Duraffour, Solenne Vigne, Kurt Vermeire, Aude Garcel, Els Vanstreels, Dirk Daelemans, Guang Yang, Robert Jordan, Dennis E Hruby, Jean-Marc Crance, Daniel Garin, Graciela Andrei, Robert Snoeck
JournalAntiviral therapy (Antivir Ther) Vol. 13 Issue 8 Pg. 977-90 ( 2008) ISSN: 1359-6535 [Print] England
PMID19195323 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Benzamides
  • Isoindoles
  • Membrane Proteins
  • RNA, Small Interfering
  • Viral Envelope Proteins
  • p37 protein, Vaccinia virus
  • tecovirimat
Topics
  • Antiviral Agents (pharmacology)
  • Benzamides (pharmacology)
  • Cell Line
  • Cowpox virus (drug effects)
  • Gene Silencing
  • Humans
  • Isoindoles (pharmacology)
  • Membrane Proteins (metabolism)
  • Orthopoxvirus (drug effects)
  • RNA, Small Interfering
  • Species Specificity
  • Vaccinia virus (drug effects)
  • Viral Envelope Proteins (metabolism)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: